Clinical Trial New Device Coverage Key For Small Firms, AbioMed Exec Says
This article was originally published in The Gray Sheet
Executive Summary
A provision authorizing Medicare to cover routine costs of clinical trials for investigational devices likely will be attached to prescription drug legislation due after lawmakers return from the Memorial Day recess June 2
You may also be interested in...
Device Industry Extols Medicare Passage Despite Competitive Bidding Thorn
AAHomecare plans to meet with CMS officials Dec. 3 to seek clarification on DME competitive bidding provisions in the Medicare reform bill, following whirlwind floor votes and last-minute negotiating
Device Industry Extols Medicare Passage Despite Competitive Bidding Thorn
AAHomecare plans to meet with CMS officials Dec. 3 to seek clarification on DME competitive bidding provisions in the Medicare reform bill, following whirlwind floor votes and last-minute negotiating
Tax Cuts, Rx Debate May Stymie Medicare Coverage Reforms – Rep. Cardin
Enacting tax cuts proposed by the Bush Administration could limit funding for Medicare reforms outside a prescription drug benefit, according to Rep. Ben Cardin (D-Md.)